Who are Epi Biologics's investors?

Epi Biologics's investors include Avego BioScience Capital, GV (Google Ventures), Mission Biocapital, Novartis Venture Fund, Roche Venture Fund, Samsara BioCapital, Taiho Ventures, LLC, Vivo Capital and 2 more.

How much funding has Epi Biologics raised?

Epi Biologics has disclosed $73M raised across 1 round.

Where is Epi Biologics headquartered?

Epi Biologics is headquartered in San Mateo, US.

Epi Biologics

San Mateo, US · Founded 2021 · 10 known investors

epibiologics.com ↗

Epibiologics develops protein degradation medicines using protein sciences and antibody engineering capabilities.

BiotechMedical Devices

Founders & leadership

Ann Lee-KarlonExecutive

Mitchell MutzNamed on SEC filing

James WellsNamed on SEC filing

Board

Samuel BjorkBoard director

Alexandra CantleyBoard director

Seiji MiyaharaBoard director

Michael KavanaughFounding Advisor

Jason ColomaBoard director

Investors · 10

Avego BioScience CapitalAlpharetta

GV (Google Ventures)Mountain View · $250K – $50M

Mission BiocapitalSan Francisco · $500K

Novartis Venture FundBasel · $5M – $25M

Roche Venture FundBasel · $648K – $3.2M

Samsara BioCapitalPalo Alto

Taiho Ventures, LLCMenlo Park

Vivo CapitalPalo Alto · $10M – $50M

Digitalis VenturesreportedNew York · $100K – $10M

Polaris PartnersreportedBoston · $500K – $5Mvia Alexandra Cantley · board

Reported raises · per SEC filings

Form D private placements

$73M disclosed across 1 round · 2022

▶$73MraisedApr 2024 · 15 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Jason ColomaDirector
Ann Lee-KarlonExecutive Officer, Director
Samuel BjorkDirector
Alexandra CantleyDirector
Mitchell MutzExecutive Officer, Director
Seiji MiyaharaDirector
James WellsDirector

Offering amount: $73M
Amount sold: $73M
First sale: Mar 2022
Incorporated: Corporation, Delaware, 2021
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 5

by search overlap

Abiologics32 shared keywordsAbiologics uses computational design tools to create protein-inspired molecules called Synteins, engineered to avoid the vulnerabilities of natural protein medicines while retaining biological function. The company develops these molecules as a new class of therapeutics with the aim of advancing candidates toward clinical development.

Peptilogics24 shared keywordsPeptilogics is a clinical-stage surgical therapeutics company developing zaloganan (PLG0206), a novel anti-biofilm drug to treat and prevent medical device-related infections such as prosthetic joint infections. Its lead candidate is in a pivotal Phase 2/3 trial and holds FDA Orphan Disease, Fast Track, and QIDP designations.

Bioworld22 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Epicrispr Biotechnologies21 shared keywordsEpicrispr Biotechnologies develops therapies that dynamically control gene expression using the epigenome to treat complex diseases. Its Gene Expression Modulation System (GEMS) platform combines epigenomic modulators to build therapies customized for specific disease indications.

Epics Therapeutics19 shared keywordsEPICS Therapeutics develops RNA epigenetics-based cancer treatments, focusing on METTL3 inhibitors for cancers including non-small cell lung cancer, pancreatic cancer, ovarian cancer, and colorectal cancer where existing therapies are insufficient.

Companies competing with Epi Biologics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Epi Biologics do?: Epibiologics develops protein degradation medicines using protein sciences and antibody engineering capabilities.
Who are Epi Biologics's investors?: Epi Biologics's investors include Avego BioScience Capital, GV (Google Ventures), Mission Biocapital, Novartis Venture Fund, Roche Venture Fund, Samsara BioCapital, Taiho Ventures, LLC, Vivo Capital and 2 more.
How much funding has Epi Biologics raised?: Epi Biologics has disclosed $73M raised across 1 round.
Where is Epi Biologics headquartered?: Epi Biologics is headquartered in San Mateo, US.